| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 10, 2006
Revised on August 11, 2006
Accepted on August 16, 2006
From the Department of Medicine I (M.H., N.B., R.W., O.R.); Institute of Physiology (K.S.); and Rudolf-Virchow-Center (S.E.), DFG-Research Center for Experimental Biomedicine, University of Wuerzburg, Germany; University Department of Medicine (M.H.B., L.N.), Manchester Royal Infirmary, UK; and Department II (L.H.), Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany.
* To whom correspondence should be addressed. E-mail: Ritter_O{at}klinik.uni-wuerzburg.de.
The time that transcription factors remain nuclear is a major determinant for transcriptional activity. It has recently been demonstrated that the phosphatase calcineurin is translocated to the nucleus with the transcription factor nuclear factor of activated T cells (NF-AT). This study identifies a nuclear localization sequence (NLS) and a nuclear export signal (NES) in the sequence of calcineurin. Furthermore we identified the nuclear cargo protein importin
1 to be responsible for nuclear translocation of calcineurin. Inhibition of the calcineurin/importin interaction by a competitive peptide (KQECKIKYSERV), which mimicked the calcineurin NLS, prevented nuclear entry of calcineurin. A noninhibitory control peptide did not interfere with the calcineurin/importin binding. Using this approach, we were able to prevent the development of myocardial hypertrophy. In angiotensin II-stimulated cardiomyocytes, [3H]-leucine incorporation (159%±9 versus 111%±11; P<0.01) and cell size were suppressed significantly by the NLS peptide compared with a control peptide. The NLS peptide inhibited calcineurin/NF-AT transcriptional activity (227%±11 versus 133%±8; P<0.01), whereas calcineurin phosphatase activity was unaffected (298%±9 versus 270%±11; P=NS). We conclude that calcineurin is not only capable of dephosphorylating NF-AT, thus enabling its nuclear import, but the presence of calcineurin in the nucleus is also important for full NF-AT transcriptional activity.
This article has been cited by other articles:
![]() |
M. N. Chahine and G. N. Pierce Therapeutic Targeting of Nuclear Protein Import in Pathological Cell Conditions Pharmacol. Rev., September 1, 2009; 61(3): 358 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Bootman, C. Fearnley, I. Smyrnias, F. MacDonald, and H. L. Roderick An update on nuclear calcium signalling J. Cell Sci., July 15, 2009; 122(14): 2337 - 2350. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Das, S. Gupta, A. Vasanji, Z. Xu, S. Misra, and S. Sen Nuclear Co-translocation of Myotrophin and p65 Stimulates Myocyte Growth: REGULATION BY MYOTROPHIN HAIRPIN LOOPS J. Biol. Chem., October 10, 2008; 283(41): 27947 - 27956. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jeong, J. M. Kim, H. Cha, J. G. Oh, J. Park, S.-H. Yun, E.-S. Ju, E.-S. Jeon, R. J. Hajjar, and W. J. Park PICOT Attenuates Cardiac Hypertrophy by Disrupting Calcineurin-NFAT Signaling Circ. Res., March 28, 2008; 102(6): 711 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Frank, C. Kuhn, M. van Eickels, D. Gehring, C. Hanselmann, S. Lippl, R. Will, H. A. Katus, and N. Frey Calsarcin-1 Protects Against Angiotensin-II Induced Cardiac Hypertrophy Circulation, November 27, 2007; 116(22): 2587 - 2596. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Philips, J. C. Kwok, and B. H. Chong Analysis of the Signals and Mechanisms Mediating Nuclear Trafficking of GATA-4: LOSS OF DNA BINDING IS ASSOCIATED WITH LOCALIZATION IN INTRANUCLEAR SPECKLES J. Biol. Chem., August 24, 2007; 282(34): 24915 - 24927. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |